| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| iTeos Therapeutics, Inc. | Chief Executive Officer, Director | Common Stock | 0 | $0 | $10.29 | 29 Aug 2025 | By MG3A |
| iTeos Therapeutics, Inc. | Chief Executive Officer, Director | Common Stock | 0 | $0 | $10.29 | 29 Aug 2025 | Direct |
| Vor Biopharma Inc. | Director | Stock Option (right to buy) | 60,000 | 16 Jul 2025 | Direct | ||
| iTeos Therapeutics, Inc. | Chief Executive Officer, Director | Stock Option (Right to Buy) | 0 | 29 Aug 2025 | By MG3A | ||
| iTeos Therapeutics, Inc. | Chief Executive Officer, Director | Stock Option (Right to Buy) | 0 | 29 Aug 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ITOS | iTeos Therapeutics, Inc. | 29 Aug 2025 | 9 | $0 | 4 | Chief Executive Officer, Director | 29 Aug 2025, 16:30 |
| VOR | Vor Biopharma Inc. | 16 Jul 2025 | 1 | $0 | 4 | Director | 18 Jul 2025, 17:16 |
| VOR | Vor Biopharma Inc. | 16 Jul 2025 | 0 | $0 | 3 | Director | 18 Jul 2025, 17:12 |
| ITOS | iTeos Therapeutics, Inc. | 09 Jun 2025 | 16 | -$116,919 | 4 | Chief Executive Officer | 11 Jun 2025, 21:01 |
| ITOS | iTeos Therapeutics, Inc. | 04 Jun 2025 | 18 | -$918,078 | 4 | Chief Executive Officer | 06 Jun 2025, 21:03 |
| ITOS | iTeos Therapeutics, Inc. | 07 Mar 2025 | 2 | $0 | 4 | Chief Executive Officer | 11 Mar 2025, 20:00 |
| ITOS | iTeos Therapeutics, Inc. | 08 Aug 2024 | 2 | $0 | 4 | Chief Executive Officer | 09 Aug 2024, 20:00 |
| ITOS | iTeos Therapeutics, Inc. | 07 Mar 2024 | 1 | $0 | 4 | Chief Executive Officer | 08 Mar 2024, 19:57 |
| ITOS | iTeos Therapeutics, Inc. | 05 Dec 2023 | 1 | $0 | 4 | Chief Executive Officer | 07 Dec 2023, 20:20 |
| ITOS | iTeos Therapeutics, Inc. | 09 Mar 2023 | 3 | $0 | 4 | Chief Executive Officer | 10 Mar 2023, 18:51 |
| ITOS | iTeos Therapeutics, Inc. | 31 Dec 2022 | 2 | $0 | 5 | Chief Executive Officer | 10 Mar 2023, 18:50 |
| ITOS | iTeos Therapeutics, Inc. | 18 Apr 2022 | 4 | -$317,885 | 4 | Chief Executive Officer | 19 Apr 2022, 19:59 |
| ITOS | iTeos Therapeutics, Inc. | 21 Mar 2022 | 4 | -$629,987 | 4 | Chief Executive Officer | 22 Mar 2022, 20:05 |
| ITOS | iTeos Therapeutics, Inc. | 11 Mar 2022 | 2 | $0 | 4 | Chief Executive Officer | 14 Mar 2022, 19:59 |
| ITOS | iTeos Therapeutics, Inc. | 23 Feb 2022 | 2 | -$497,905 | 4 | Chief Executive Officer | 24 Feb 2022, 19:00 |
| ITOS | iTeos Therapeutics, Inc. | 25 Jan 2022 | 2 | -$517,378 | 4 | Chief Executive Officer | 26 Jan 2022, 18:53 |
| ITOS | iTeos Therapeutics, Inc. | 02 Dec 2021 | 23 | -$1,853,131 | 4 | Chief Executive Officer | 22 Dec 2021, 19:01 |
| ITOS | iTeos Therapeutics, Inc. | 22 Nov 2021 | 3 | -$320,686 | 4 | Chief Executive Officer | 24 Nov 2021, 18:59 |
| ITOS | iTeos Therapeutics, Inc. | 01 Nov 2021 | 3 | -$586,966 | 4 | Chief Executive Officer | 03 Nov 2021, 19:59 |
| ITOS | iTeos Therapeutics, Inc. | 21 Oct 2021 | 1 | -$5,488 | 4 | Chief Executive Officer | 25 Oct 2021, 20:00 |
| ITOS | iTeos Therapeutics, Inc. | 15 Oct 2021 | 2 | -$51,424 | 4 | Chief Executive Officer | 19 Oct 2021, 20:01 |
| ITOS | iTeos Therapeutics, Inc. | 23 Sep 2021 | 2 | -$180,374 | 4 | Chief Executive Officer | 27 Sep 2021, 20:00 |
| ITOS | iTeos Therapeutics, Inc. | 01 Sep 2021 | 3 | -$580,518 | 4 | Chief Executive Officer | 03 Sep 2021, 20:01 |
| ITOS | iTeos Therapeutics, Inc. | 27 Aug 2021 | 3 | -$412,481 | 4 | Chief Executive Officer | 31 Aug 2021, 20:00 |
| ITOS | iTeos Therapeutics, Inc. | 23 Aug 2021 | 3 | -$240,890 | 4 | Chief Executive Officer | 25 Aug 2021, 20:04 |
| ITOS | iTeos Therapeutics, Inc. | 14 Jun 2021 | 2 | -$826,534 | 4 | Chief Executive Officer, Director | 16 Jun 2021, 18:48 |